Document is current

Article History

Accepted: 16 July 2024

First Online: 23 July 2024

Declarations

:

: Dr. Fudim was supported by the NIH, Bodyport, Sardocor, and Doris Duke. He is a consultant/has ownership interesting in Abbott, Ajax, Alio Health, Alleviant, Analog, Andera, Artha, Audicor, AxonTherapies, Bayer, Bodyguide, Bodyport, Boston Scientific, Broadview, Cadence, Cardioflow, Coridea, CVRx, Daxor, Edwards Lifesciences, Echosens, EKO, Feldschuh Foundation, Fire1, FutureCardia, Galvani, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, Intershunt, Medtronic, Merck, NIMedical, NovoNordisk, NucleusRx, NXT Biomedical, Orchestra, Pharmacosmos, Presidio, Procyreon, Proton Intelligence, ReCor, Rockley, SCPharma, Shifamed, Splendo, STAT Health, Summacor, SyMap, Verily, Vironix, Viscardia, Zoll. Dr. Nunez reports honoraria for presentations or advisory boards from Alleviant, AstraZeneca, Boehringer Ingelheim, Bayer, Novartis, Novo Nordisk, Pfizer, Roche, Rovi, and Vifor CSL (outside the submitted work). Dr. Yaku has received research grant support from Boston Scientific. Dr. Espriela reports honoraria for presentations or advisory boards from AstraZeneca, Boehringer Ingelheim, Bayer, Novartis, Novo Nordisk, Pfizer, Roche, Rovi, and Vifor CSL (outside the submitted work). Dr. Biering-Sørensen has received research grants from Sanofi Pasteur, GSK, Novo Nordisk, AstraZeneca, Boston Scientific and GE Healthcare, consulting fees from Novo Nordisk, IQVIA, Parexel, Amgen, CSL Seqirus, GSK and Sanofi Pasteur, and lecture fees from Bayer, Novartis, Sanofi Pasteur, GE Healthcare and GSK (outside the submitted work).